Costco offers members access to GLP-1 weight-loss drugs
Members of the warehouse club can now sign up for a service that offers access to drugs like Ozempic.
Watch CBS News
Members of the warehouse club can now sign up for a service that offers access to drugs like Ozempic.
Doctors are seeing more women turn to weight-loss drugs ahead of pregnancy. Studies show that being overweight can increase the chances of pregnancy complications, including miscarriages. And while the FDA does not authorize the use of weight loss medications during pregnancy, there is limited information on their effects before conception. Dr. Ilana Ramer Bass, an assistant professor in the division of endocrinology, diabetes and metabolism at Mount Sinai, joined CBS News to discuss the trend.
Several clinical trials are underway to see if semaglutide, the active ingredient in weight loss drugs like Wegovy and Ozempic, can also help treat alcohol addiction.
Doctors are seeing a surprising possible side effect of weight loss drugs like Ozempic and Wegovy: a diminished craving for alcohol. Janet Shamlian reports.
GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year. What does that mean for the overweight or obese?
Ozempic and other GLP-1 class medications are being proven beneficial for reducing cardiovascular risk and treating diabetes. But they also signal fullness to the brain and regulate blood sugar, allowing people to lose on average 10 to 20 percent of their body weight in the first year. For many of the roughly 74 percent of Americans who are overweight or obese, that's almost unimaginable. Correspondent Susan Spencer talks with doctors and patients about how these drugs work, and why they are considered life-changing (and even, for Wall Street analysts, a miracle).
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
The FDA and drugmaker Novo Nordisk are working to identify thousands of counterfeit Ozempic drugs seized in an ongoing investigation.
WeightWatchers program aims to help members maintain healthy habits while taking anti-obesity drugs like Ozempic and Wegovy.
America's Poison Centers, a group that represents poison control centers across the U.S., reported a major spike in calls this year related to semaglutide, the main ingredient in weight loss drugs such as Ozempic and Wegovy.
In an interview with People, Oprah Winfrey revealed that she recently turned to a weight-loss medication after years of struggling with her weight.
Food companies are trying to capitalize on the popular weight-loss drug Ozempic. According to new reporting from The Wall Street Journal, companies like Nestle and General Mills are working on products to pitch as natural alternatives or companion products for people taking Ozempic to use in addition to the weight loss drug. Jesse Newman, a reporter for The Wall Street Journal covering food and agriculture, joined CBS News to discuss the trend.
According to data, while Black people are much more likely to suffer from obesity and diabetes, white people are four times more likely to get a prescription.
Doctors across the country are dealing with soaring demand for injectable weight-loss drugs, especially among people who are not clinically obese. Drugs like Ozempic and Wegovy have proved to be especially effective for weight loss, but some health experts are worried their increased use could potentially be harmful to certain patients. Dr. Shauna Levy, medical director of Tulane's Bariatric and Weight Loss Center, joined CBS News to discuss the medications.
The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
It is unclear if the counterfeit drugs, which many people seek for weight loss, caused the hospitalizations.
The popularity of like Ozempic and Wegovy for weight loss may already be impacting consumption habits by helping consumers suppress their appetite. CBS MoneyWatch reporter Megan Cerullo reports the hunger suppressors also have the potential to boost demand for healthier foods and activities like going to the gym.
Popular weight loss drugs Ozempic and Wegovy have been linked to an increased risk of severe stomach problems, including pancreatitis and stomach paralysis. CBS News' Elaine Quijano reports on the new JAMA study.
Weight loss drugs could have economic side effect, experts say
The warning about scams comes as sales have boomed for Ozempic, Wegovy and other drugs used for weight loss.
The FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
The use of popular diabetes drugs like Ozempic and Wegovy has exploded worldwide because of their weight loss benefits, but some users are now reporting another possible side effect: reducing cravings for alcohol, nicotine and even opioids. Dr. Tamika Henry, founder of the Unlimited Health Institute, joined CBS News to explain the potential benefits.
While Ozempic's interaction with the reward centers in our brain could help explain this, Dr. Tamika Henry, founder of Unlimited Health Institute, says more studies are needed.